Warren Butt, MD
Gastroenterology · Newark, DENPI 1427129436
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,426 of the $1,926 with a category attached, or 74.0%. 18 manufacturers reported payments, led by AbbVie at 34.2% of the total. Reporting peaked in 2019 at $773 and has fallen 85.7% since, to $111 in 2025. That places this record below the midpoint for gastroenterology clinicians in DE, where the typical reported total is $2,631.
Across 68 payments — averaging $28.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$660
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$500
- Medical Device Business Services, Inc.$120
- E.r. Squibb & Sons, L.L.C.$120
- Pfizer$100
- Bristol Myers Squibb$98
- plus $328 from 12 others
What the payments were for
- Speaking & faculty fees$50026%
- Food & beverage$1,42674%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $660 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $500 |
| Medical Device Business Services, Inc. | 1 | $120 |
| E.r. Squibb & Sons, L.L.C. | 1 | $120 |
| Pfizer | 7 | $100 |
| Bristol Myers Squibb | 5 | $98 |
| Gilead | 4 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Micro-tech Endoscopy USA, Inc. | 2 | $37 |
| Johnson & Johnson | 2 | $30 |
| Olympus America Inc. | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Axonics, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Shionogi Inc | 1 | $17 |
| Medtronic | 1 | $15 |
| Madrigal Pharmaceuticals | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELISTOR$500
- XIFAXAN$500
- LINX Reflux Management System$120
How this compares
$1,926 in reported general payments places this provider in the 40th percentile of 50 gastroenterology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 37 | $258,522 |
| CreonLipase/Protease/Amylase | 39 | $67,955 |
| Mesalamine | 19 | $12,546 |
| Omeprazole | 511 | $9,832 |
| Mesalamine ErMesalamine | 16 | $8,205 |
| Dexlansoprazole DrDexlansoprazole | 19 | $5,399 |
| Ursodiol | 15 | $3,760 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 15 | $2,822 |
| Esomeprazole Magnesium | 31 | $1,863 |
| Pantoprazole Sodium | 69 | $1,570 |
| Famotidine | 67 | $1,183 |
| Lansoprazole | 24 | $569 |
| Levofloxacin | 18 | $95 |
| Metoclopramide Hcl | 16 | $62 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $660 | $67,95539 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $18 | $2,82215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 50 gastroenterology providers in Delaware.
Other gastroenterology in Newark
- Michael BrooksNewark$48K
- Jorge UribeNewark$11K
- Laura ConnorNewark$11K
- Gaurav JainNewark$10K
- Jared HossackNewark$9K
- Melissa VitoloNewark$8K
- Christine HerdmanNewark$7K
- Scott MeyersonNewark$7K
- Thirumaleshawar KanchanaNewark$7K
- Hasan AliNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.